DENTSPLY SIRONA Inc. 8-K

What Happened
DENTSPLY SIRONA (XRAY) announced in an 8-K filed June 11, 2026 that its Board appointed John C. Fortson as Executive Vice President & Chief Financial Officer effective July 20, 2026. Mr. Fortson joins from Kymera International, where he served as President and CFO, and previously was President & CEO and CFO at Ingevity. The Company and Mr. Fortson executed an offer letter (dated May 30, 2026) that sets his compensation and related terms.

Key Details

• Base salary: $780,000 per year.
• Annual bonus: target of 85% of base salary (prorated for 2026).
• Equity: eligible for an annual equity award beginning 2027 with a target grant date fair value of $2,500,000; initial sign‑on equity award target $700,000 (60% options, 40% RSUs) with three‑year ratable vesting.
• Sign‑on cash: $500,000 payable in first pay period in Feb 2027; must be repaid if employment ends within 12 months for any reason other than involuntary, not‑for‑cause termination.
• Other terms: participation in standard benefits and executive retirement/savings plans, subject to company severance and change‑of‑control plans, and a confidentiality/non‑compete agreement (two‑year non‑compete post‑employment with exceptions).

Why It Matters
This 8-K reports a senior leadership change: a new CFO can affect financial reporting, investor communications and capital allocation decisions. The filing gives investors concrete, near‑term cost and incentive details (salary, bonus targets, sign‑on cash and equity) that affect compensation expense and align the new CFO’s incentives with the company. The non‑compete, severance and change‑of‑control provisions are standard governance items investors monitor for succession and retention risk.